Skip to main content
. 2020 Jan 10;99(2):e18670. doi: 10.1097/MD.0000000000018670

Figure 3.

Figure 3

Representative fluorescent in situ hybridization findings for patients with B-cell lymphomas. (A) Interferon regulatory factor 4 (IRF4) rearrangement and no IRF4 translocation. (B) B-cell lymphoma (BCL)-2 rearrangement and no BCL-2 translocation. (C) BCL-6 rearrangement and no BCL-6 translocation. (D) C-MYC rearrangement and no C-MYC translocation. MYC = myelocytomatosis viral oncogeneav.